HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jean-Pierre Routy Selected Research
Jean-Pierre Routy Research Topics
Disease
75
Infections
02/2024 - 02/2002
64
HIV Infections (HIV Infection)
01/2024 - 03/2003
42
Inflammation (Inflammations)
05/2024 - 01/2014
34
Acquired Immunodeficiency Syndrome (AIDS)
07/2023 - 11/2002
22
Disease Progression
12/2023 - 04/2007
16
Neoplasms (Cancer)
01/2024 - 12/2009
14
COVID-19
01/2024 - 01/2020
14
Virus Diseases (Viral Diseases)
07/2023 - 01/2010
10
Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 01/2017
10
Persistent Infection
10/2023 - 03/2002
7
Atherosclerosis
05/2024 - 06/2020
6
Viremia
01/2021 - 02/2002
4
Kaposi Sarcoma (Kaposi's Sarcoma)
01/2021 - 11/2002
3
Pancytopenia
01/2024 - 01/2021
3
Body Weight (Weight, Body)
08/2023 - 01/2020
3
Non-alcoholic Fatty Liver Disease
08/2023 - 11/2016
3
Dysbiosis
01/2023 - 04/2016
2
Autoimmune Diseases (Autoimmune Disease)
01/2024 - 03/2013
2
Dyslipidemias (Dyslipidemia)
01/2024 - 09/2020
2
Castleman Disease (Castleman's Disease)
01/2023 - 01/2021
2
Atherosclerotic Plaque (Atheroma)
12/2022 - 07/2009
2
Cytokine Release Syndrome
01/2022 - 01/2017
2
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2021 - 01/2020
2
Pneumonia (Pneumonitis)
10/2021 - 09/2009
2
Ulcerative Colitis
03/2021 - 01/2021
2
Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2021 - 07/2018
2
Weight Loss (Weight Reduction)
09/2020 - 01/2020
2
Hepatitis
10/2018 - 07/2018
2
Breast Neoplasms (Breast Cancer)
12/2017 - 01/2016
2
Liver Cirrhosis (Hepatic Cirrhosis)
11/2016 - 03/2016
2
Multi-centric Castleman's Disease
06/2008 - 11/2002
Drug/Important Bio-Agent (IBA)
25
Cytokines
IBA
05/2024 - 11/2005
19
Biomarkers (Surrogate Marker)
IBA
01/2024 - 09/2008
13
Vaccines
IBA
10/2023 - 07/2007
11
DNA (Deoxyribonucleic Acid)
IBA
05/2024 - 11/2002
9
Antiviral Agents (Antivirals)
IBA
01/2022 - 11/2005
9
Tryptophan (L-Tryptophan)
FDA Link
01/2021 - 10/2014
9
Kynurenine
IBA
01/2021 - 01/2015
8
Interleukin-18 (Interleukin 18)
IBA
01/2021 - 06/2009
7
Proteins (Proteins, Gene)
FDA Link
10/2023 - 05/2005
7
Antigens
IBA
07/2023 - 02/2002
7
Peptides (Polypeptides)
IBA
01/2016 - 03/2002
6
Protein Isoforms (Isoforms)
IBA
05/2024 - 12/2019
6
Metformin (Glucophage)
FDA Link
Generic
02/2024 - 01/2019
6
RNA (Ribonucleic Acid)
IBA
12/2022 - 01/2012
6
Protease Inhibitors (Protease Inhibitor)
IBA
11/2016 - 02/2002
5
Chemokines
IBA
11/2023 - 12/2015
5
Enzymes
IBA
01/2016 - 08/2011
5
Interleukin-2 (IL2)
IBA
01/2016 - 05/2009
5
HLA-B57 antigen
IBA
01/2014 - 07/2007
4
Interleukins
IBA
05/2024 - 12/2003
4
Growth Differentiation Factor 15
IBA
01/2024 - 01/2020
4
Lipopolysaccharide Receptors
IBA
01/2024 - 01/2014
4
Immunoglobulin G (IgG)
IBA
12/2023 - 12/2020
4
Lipopolysaccharides
IBA
01/2023 - 01/2020
4
interleukin-21 (interleukin 21)
IBA
01/2022 - 09/2008
4
Rituximab (Mabthera)
FDA Link
01/2021 - 06/2008
4
Interleukin-7 (Interleukin 7)
IBA
01/2017 - 01/2012
4
Ligands
IBA
10/2016 - 11/2010
4
HLA-B Antigens (HLA-B)
IBA
10/2016 - 07/2008
3
Lipids
IBA
01/2024 - 12/2020
3
Immune Checkpoint Inhibitors
IBA
01/2024 - 01/2022
3
trans-crotonin (CTN)
IBA
10/2023 - 12/2021
3
Messenger RNA (mRNA)
IBA
10/2023 - 01/2016
3
Transcription Factors (Transcription Factor)
IBA
10/2023 - 03/2008
3
Interleukin-17 (Interleukin 17)
IBA
11/2021 - 01/2020
3
MicroRNAs (MicroRNA)
IBA
04/2021 - 11/2015
3
Hypoglycemic Agents (Hypoglycemics)
IBA
10/2020 - 01/2019
3
Glucose (Dextrose)
FDA Link
Generic
10/2020 - 01/2018
3
Interleukin-33
IBA
01/2017 - 01/2016
3
Interferon-gamma (Interferon, gamma)
IBA
11/2014 - 03/2002
3
KIR Receptors
IBA
01/2014 - 03/2008
3
Reverse Transcriptase Inhibitors
IBA
03/2009 - 03/2005
3
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
12/2004 - 02/2002
2
Interleukin-6 (Interleukin 6)
IBA
01/2024 - 03/2016
2
C-Reactive Protein
IBA
01/2024 - 02/2017
2
Keratin-18 (Keratin 18)
IBA
08/2023 - 01/2020
2
Integrases
IBA
08/2023 - 01/2018
2
Fatty Acid-Binding Proteins
IBA
01/2023 - 03/2016
2
Interleukin-10 (Interleukin 10)
IBA
12/2022 - 04/2010
2
Antibodies
IBA
11/2021 - 01/2018
2
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
01/2021 - 01/2016
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2021 - 01/2013
2
Interleukin-12 (IL 12)
IBA
01/2021 - 06/2009
2
AIDS Vaccines
IBA
01/2020 - 09/2017
2
Human Immunodeficiency Virus Proteins
IBA
01/2019 - 01/2007
2
TNF Receptor-Associated Factor 1
IBA
01/2018 - 01/2012
2
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
12/2017 - 01/2016
2
Alarmins
IBA
01/2017 - 01/2016
2
Natural Killer Cell Receptors
IBA
10/2016 - 07/2008
2
Epitopes
IBA
11/2014 - 11/2005
2
Broadly Neutralizing Antibodies
IBA
05/2013 - 06/2011
2
Integrins
IBA
01/2012 - 04/2011
2
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2012 - 04/2011
2
Nucleosides
IBA
04/2008 - 03/2005
Therapy/Procedure
41
Therapeutics
01/2024 - 02/2002
35
Art Therapy
02/2024 - 08/2015
14
Immunotherapy
01/2024 - 12/2009
6
Highly Active Antiretroviral Therapy (HAART)
01/2016 - 03/2003
4
Drug Therapy (Chemotherapy)
01/2022 - 03/2003